Chemical chaperone therapy for GM1-gangliosidosis Y. Suzuki Visions & Reflections (Minireview) 19 January 2008 Pages: 351 - 353
Aspirin: recent developments O. YasudaY. TakemuraH. Rakugi Visions & Reflections (Minireview) 26 November 2007 Pages: 354 - 358
Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer’s disease K. TakahashiC. UchidaT. Uchida Review 29 October 2007 Pages: 359 - 375
Pannexins and gap junction protein diversity V. I. ShestopalovY. Panchin Review 05 November 2007 Pages: 376 - 394
Hyaluronan synthesis and degradation in cartilage and bone E. R. BastowS. ByersA. J. Fosang Review 29 October 2007 Pages: 395 - 413
Histone chaperones: 30 years from isolation to elucidation of the mechanisms of nucleosome assembly and disassembly M. EitokuL. SatoM. Horikoshi Review 22 October 2007 Pages: 414 - 444
The Penicillium chrysogenum antifungal protein PAF, a promising tool for the development of new antifungal therapies and fungal cell biology studies F. MarxU. BinderI. Pócsi Review 29 October 2007 Pages: 445 - 454
Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin J. LubelskiR. RinkO. P. Kuipers Review 29 October 2007 Pages: 455 - 476
Involvement of small Ras GTPases and their effectors in chronic renal disease C. Martínez-SalgadoA. B. Rodríguez-PeñaJ. M. López-Novoa Review 05 November 2007 Pages: 477 - 492
Bacterial pore-forming toxins: The (w)hole story? M. R. GonzalezM. BischofbergerB. Frêche Review 09 November 2007 Pages: 493 - 507
